📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation. (2021)

First Author: Yiangou A

Attributed to: MICA: Assessing the therapeutic efficacy of 11beta-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in idiopathic intracranial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/head.14026

PubMed Identifier: 33316102

Publication URI: http://europepmc.org/abstract/MED/33316102

Type: Journal Article/Review

Volume: 61

Parent Publication: Headache

Issue: 1

ISSN: 0017-8748